Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 Aug 10;303(6798):363–364.

Drugs, HIV, and prisons.

PMCID: PMC1670766  PMID: 1912787

Full text

PDF

Page 363

363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dye S., Isaacs C. Intravenous drug misuse among prison inmates: implications for spread of HIV. BMJ. 1991 Jun 22;302(6791):1506–1506. doi: 10.1136/bmj.302.6791.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Farrell M., Strang J. Drugs, HIV, and prisons. BMJ. 1991 Jun 22;302(6791):1477–1478. doi: 10.1136/bmj.302.6791.1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jeanmonod R., Harding T., Staub C. Treatment of opiate withdrawal on entry to prison. Br J Addict. 1991 Apr;86(4):457–463. doi: 10.1111/j.1360-0443.1991.tb03423.x. [DOI] [PubMed] [Google Scholar]
  4. Martin W. R., Jasinski D. R., Mansky P. A. Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Arch Gen Psychiatry. 1973 Jun;28(6):784–791. doi: 10.1001/archpsyc.1973.01750360022003. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES